Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
Libster R, Pérez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, Esteban I, Caballero MT, Wood C, Berrueta M, Rondan A, Lescano G, Cruz P, Ritou Y, Fernández Viña V, Álvarez Paggi D, Esperante S, Ferreti A, Ofman G, Ciganda Á, Rodriguez R, Lantos J, Valentini R, Itcovici N, Hintze A, Oyarvide ML, Etchegaray C, Neira A, Name I, Alfonso J, López Castelo R, Caruso G, Rapelius S, Alvez F, Etchenique F, Dimase F, Alvarez D, Aranda SS, Sánchez Yanotti C, De Luca J, Jares Baglivo S, Laudanno S, Nowogrodzki F, Larrea R, Silveyra M, Leberzstein G, Debonis A, Molinos J, González M, Perez E, Kreplak N, Pastor Argüello S, Gibbons L, Althabe F, Bergel E, Polack FP; Fundación INFANT–COVID-19 Group. Libster R, et al. Among authors: larrea r. N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6. N Engl J Med. 2021. PMID: 33406353 Free PMC article. Clinical Trial.
Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
Cannellotto M, Duarte M, Keller G, Larrea R, Cunto E, Chediack V, Mansur M, Brito DM, García E, Di Salvo HE, Verdini F, Domínguez C, Jorda-Vargas L, Roberti J, Di Girolamo G, Estrada E. Cannellotto M, et al. Among authors: larrea r. Emerg Med J. 2022 Feb;39(2):88-93. doi: 10.1136/emermed-2021-211253. Epub 2021 Dec 14. Emerg Med J. 2022. PMID: 34907003 Free PMC article. Clinical Trial.
[Cardiologist training in Chile and contributions from the Chilean Society of Cardiology and Cardiovascular Surgery].
Rossel V, Gajardo J, Miranda R, Nauhm Y, Larrea R, Greig D, Fernández F, Bittner A, Aguayo R, Varleta P, Sanhueza G, Bugueño C, Quiñiñir L, Llancaqueo M, Pedemonte O, Julio P, Sepúlveda L, Oyonarte M; en representación de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular.. Rossel V, et al. Among authors: larrea r. Rev Med Chil. 2024 Feb;152(2):235-243. doi: 10.4067/s0034-98872024000200235. Rev Med Chil. 2024. PMID: 39450800 Free article. Spanish.
A modular cell-free protein biosensor platform using split T7 RNA polymerase.
McSweeney MA, Patterson AT, Loeffler K, de Larrea RCL, McNerney MP, Kane RS, Styczynski MP. McSweeney MA, et al. Among authors: de larrea rcl. bioRxiv [Preprint]. 2024 Jul 19:2024.07.19.604303. doi: 10.1101/2024.07.19.604303. bioRxiv. 2024. PMID: 39071415 Free PMC article. Preprint.
[Concordance between the test of the tuberculin and Interferon Gamma Release Assay-IGRA in patients with immune-mediated inflammatory diseases].
Pérez Catalán I, Roig Martí C, Gil Fortuño M, Torrent Ramos P, Albiol Viñals P, Carballido Fernández M, Larrea RM, Ortín Martín C, Usó Blasco J, Ramos Rincón JM. Pérez Catalán I, et al. Among authors: larrea rm. Rev Esp Quimioter. 2019 Oct;32(5):445-450. Epub 2019 Sep 16. Rev Esp Quimioter. 2019. PMID: 31523944 Free PMC article. Spanish.
[Assessment of moral competence of physicians].
Agurto M, Tello D, Elgueta A, Larrea R, Minaeff T, Miranda A, Parodi E, Salas JM, Vukusich A, Llanos S, Daza P, López S. Agurto M, et al. Among authors: larrea r. Rev Med Chil. 2017 Sep;145(9):1122-1128. doi: 10.4067/s0034-98872017000901122. Rev Med Chil. 2017. PMID: 29424398 Free article. Spanish.
Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M. Bartolucci J, et al. Among authors: larrea re. Circ Res. 2017 Oct 27;121(10):1192-1204. doi: 10.1161/CIRCRESAHA.117.310712. Epub 2017 Sep 26. Circ Res. 2017. PMID: 28974553 Free PMC article. Clinical Trial.
17 results